Finance

Beta
Lists
HEM:CVE
Hemostemix Inc
CA$0.050
-9.09%
(-0.0050) 1D
Jun 5, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for HEM...
Open
CA$0.05
High
CA$0.05
Low
CA$0.05
Mkt. cap
9.07M
Avg. vol.
35.74K
Volume
4.50K
52-wk high
CA$0.16
52-wk low
CA$0.04
EPS
-CA$0.02
Beta
0.87
Shares outstanding
197.80M
Open
CA$0.05
High
CA$0.05
Low
CA$0.05
Mkt. cap
9.07M
Avg. vol.
35.74K
Volume
4.50K
52-wk high
CA$0.16
52-wk low
CA$0.04
EPS
-CA$0.02
Beta
0.87
Shares outstanding
197.80M
News stories
From sources across the web
About Hemostemix Inc
CEO-
Employees-
Founded-
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.75K
401.55K
2.08M
272.64K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
464.24K
879.88K
120.19K
353.65K
Operating expense
481.86K
1.76M
2.30M
645.85K
Total operating expenses
481.86K
1.76M
2.30M
645.85K
Operating income
-481.86K
-1.76M
-2.30M
-645.85K
Other non operating income
306.84K
315.78K
-682.37K
-113.73K
EBT including unusual items
-307.65K
-497.76K
-2.62M
-789.98K
EBT excluding unusual items
-307.65K
-1.48M
-3.15M
-926.72K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-307.65K
-497.76K
-2.62M
-789.98K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-173.12K
-193.39K
-27.51K
-141.96K
Net interest expenses
-173.12K
-193.39K
-27.51K
-141.96K
Depreciation and amortization charges
12.00
11.00
12.00
5.00
EBITDA
-481.85K
-1.76M
-2.30M
-645.84K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more